Literature DB >> 26738538

Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment.

Maite Alvarez1, Kai Sun2, William J Murphy3.   

Abstract

Natural killer (NK) cells exist as subsets based on expression of inhibitory receptors that recognize major histocompatibility complex I (MHCI) molecules. NK cell subsets bearing MHCI binding receptors for self-MHCI have been termed as "licensed" and exhibit a higher ability to respond to stimuli. In the context of bone marrow transplantation (BMT), host licensed-NK (L-NK) cells have also been demonstrated to be responsible for the acute rejection of allogeneic and MHCI-deficient BM cells (BMCs) in mice after lethal irradiation. However, the role of recipient unlicensed-NK (U-NK) cells has not been well established with regard to allogeneic BMC resistance. After NK cell stimulation, the prior depletion of host L-NK cells resulted in a marked increase of donor engraftment compared with the untreated group. Surprisingly, this increased donor engraftment was reduced after total host NK cell depletion, indicating that U-NK cells can actually promote donor allogeneic BMC engraftment. Furthermore, direct coculture of U-NK cells with allogeneic but not syngeneic BMCs resulted in increased colony-forming unit cell growth in vitro, which was at least partially mediated by granulocyte macrophage colony-stimulating factor (GM-CSF) production. These data demonstrate that host NK cell subsets exert markedly different roles in allogeneic BMC engraftment where host L- and U-NK cells reject or promote donor allogeneic BMC engraftment, respectively.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26738538      PMCID: PMC4778165          DOI: 10.1182/blood-2015-08-665570

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.

Authors:  Arati Raziuddin; Dan L Longo; Michael Bennett; Robin Winkler-Pickett; John R Ortaldo; William J Murphy
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

2.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

Authors:  Nadine C Fernandez; Emmanuel Treiner; Russell E Vance; Amanda M Jamieson; Suzanne Lemieux; David H Raulet
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

3.  Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Authors:  Sungjin Kim; Jennifer Poursine-Laurent; Steven M Truscott; Lonnie Lybarger; Yun-Jeong Song; Liping Yang; Anthony R French; John B Sunwoo; Suzanne Lemieux; Ted H Hansen; Wayne M Yokoyama
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

4.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

5.  Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.

Authors:  Crystal Y Koh; Lisbeth A Welniak; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2005-04       Impact factor: 5.742

6.  Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.

Authors:  L J Levitt; A Nagler; F Lee; J Abrams; M Shatsky; D Thompson
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.

Authors:  M K Pathak; T Yi
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

8.  Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.

Authors:  A Raziuddin; M Bennett; R Winkler-Pickett; J R Ortaldo; D L Longo; W J Murphy
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

Review 9.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know.

Authors:  Yufang Shi; Catherine H Liu; Arthur I Roberts; Jyoti Das; Guangwu Xu; Guangwen Ren; Yingyu Zhang; Liying Zhang; Zeng Rong Yuan; Hung Sheng William Tan; Gobardhan Das; Satish Devadas
Journal:  Cell Res       Date:  2006-02       Impact factor: 25.617

10.  PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells.

Authors:  Juan M Rodriguez; José Marchicio; Mariela López; Andrea Ziblat; Fernanda Elias; Juan Fló; Ricardo A López; David Horn; Jorge Zorzopulos; Alejandro D Montaner
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

View more
  5 in total

Review 1.  The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia.

Authors:  Alireza Zafarani; Mahsa Taghavi-Farahabadi; Mohammad Hossein Razizadeh; Mohammad Reza Amirzargar; Mansoure Mansouri; Mohammad Mahmoudi
Journal:  Stem Cell Rev Rep       Date:  2022-08-22       Impact factor: 6.692

2.  Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Authors:  Maite Alvarez; Antonio Pierini; Federico Simonetta; Jeanette Baker; Kristina Maas-Bauer; Toshihito Hirai; Robert S Negrin
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

Review 3.  Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity.

Authors:  Alberto Mendoza-Valderrey; Maite Alvarez; Andrea De Maria; Kim Margolin; Ignacio Melero; Maria Libera Ascierto
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

Review 4.  Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation.

Authors:  Fei Gao; Yishan Ye; Yang Gao; He Huang; Yanmin Zhao
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

5.  Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma.

Authors:  Lorena Lobo de Figueiredo-Pontes; Miroslava K Adamcova; Srdjan Grusanovic; Maria Kuzmina; Izabela Aparecida Lopes; Amanda Fernandes de Oliveira Costa; Hong Zhang; Hynek Strnad; Sanghoon Lee; Alena Moudra; Anna T Jonasova; Michal Zidka; Robert S Welner; Daniel G Tenen; Meritxell Alberich-Jorda
Journal:  Stem Cell Reports       Date:  2021-07-08       Impact factor: 7.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.